NEWS
DIAGNO BIOTECHNOLOGY WINS "WOMEN IN INNOVATION" AWARD
October 17, 2021
Özlem Ertekin, Founder of Diagno biotechnology received the "Women in Innovation award with the project "High Sensitivity and Animal-Free Affinity Molecules in Diagnostic Technologies"
DIAGNO REWARDED AT IV. BARTIN R&D PROJECT MARKET
October 26, 2021
Our project "High fidelity and animal-free affinity molecules" was rewarded at the 4th R&D project market organized by Bartın University. The project received attention from academicians and sectoral players. Detailed discussions and potential partnerships were formed during the event. The fruitful event was finalized with the recognition of our project by the Juri and our founder Özlem Ertekin received the prize from Prof. Dr. Orhan UZUN, the head of Bartın University.
DIAGNO BIOTECHNOLOGY SUPPORTS WOMEN IN SCIENCE
June 01,2024
As an R&D-oriented company, 90% of our employees and 100% of our R&D team are women. In order to support more women in science, our founder Özlem Ertekin DemirboÄŸa supported young girls who want to pursue a career in science by mentoring them in the "Bilim Kızı" program for a year. As Diagno Biotechnology, we proudly support her for her contributions to science and technology and continue to show the power of women in science.
Diagno in the Headlines!
At Diagno Biotechnology, we are dedicated to providing veterinary professionals with the best tools to diagnose and treat animals. We are proud to have been featured in the national press Sabah newspaper for our leadership as the first Ministry of Agriculture and Forestry approved veterinary diagnostic kit producer.
Our innovative solutions and commitment to excellence have made us the go-to choice for veterinary professionals across the country. Thank you for choosing Diagno Biotechnology for your veterinary diagnostics needs!
ÖZLEM ERTEKÄ°N​ "LESS PLASTIC IN DIAGNOSTIC KITS"
​​
The main raw material used in diagnostic kits are called “affinity molecules”, allowing us to distinguish one disease from another. These materials are produced specifically for each disease in the same way that a key is specific to a lock, meaning that a different key is designed for opening each door. The most widely used "key" in the world are molecules called “antibodies”, which are produced by the immune system of animals. In some cases more than half of the cost of a kit can be consisting of antibodies. The “affinity peptides” we are planning to produce will be able to bind the key to the target disease just like antibodies fit the lock, eliminating the use of animal products as well as reducing the use of plastic and reducing costs.
OUR WOMAN SCIENTISTS ARE MARKING THE HISTORY
With the cooperation of KADEM, TÜBÄ°TAK Marmara Teknokent, BiliÅŸim Vadisi and KOSGEB, took action to increase women's entrepreneurial courage and support them to make their projects come true into enterprises with high employment potential. In the 6th Women in Innovation Project, five finalist women entrepreneurs demonstrated that they could change the history of science with the projects they developed.
Diagno Biotechnology Supports Practices in Bioengineering
Diagno Biotechnology attended the VIII: Bioengineering Congress on 16-18 May of 2024.